Press release
Drug Eluting Balloon Catheter Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022
Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures. Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favourably on the global sales of the drug eluting balloon catheter. Also, companies are aiming to manufacture cost-effective catheters that in order to increase market penetration. Growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug eluting balloon catheter market. Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022. In addition, factors such as enhanced reimbursement policies, rising geriatric population and growing healthcare expenditure are anticipated to positively impact the market’s growth. The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipate to create lucrative growth opportunities for manufacturers and stakeholder in the global market for drug eluting balloon catheter.Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=146
Key Insights From the Report Include:
Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness a robust growth over the next couple of years.
By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, coronary artery disease indication segment will command for more than two-third revenue share of the global market.
Hospitals will remain the largest end user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently commands for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.
By raw material, demand nylon based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards to the end of 2022, more than US$ 244 Mn worth nylon drug eluting balloon catheters are expected to be sold worldwide.
Browse Full Report with TOC- https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market
Competition Tracking
Fact.MR’s report has also mentioned some of the key players functioning in the global market for drug eluting balloon catheter, which include Medtronic Plc., Cook Medical INC, Abbott Laboratories, Jotech GmbH, Terumo Corporation, Tokai Medical Products Inc., B. Braun Melsungen AG, Cardionovum GmbH, Cordis Corporation, Meril Life Sciences Pvt Ltd, MicroPort Scientific Corporation, Boston Scientific Corporation, and BIOTRONIK SE & Co. KG
Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=146
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Balloon Catheter Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022 here
News-ID: 813912 • Views: …
More Releases from Factmr

Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research …
The biobanking industry stands at the threshold of a decade-long expansion trajectory that promises to reshape biological sample storage and research infrastructure technology. The market's journey from USD 68.5 billion in 2025 to USD 147.9 billion by 2035 This expansion underscores the industry's pivotal role in modernizing biological sample storage and advancing research infrastructure for pharmaceutical and biotechnology applications.
Biobanking's critical contribution to personalized medicine, drug discovery, and disease research positions…

Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveil …
The global Biopharmaceutical Packaging Market is entering a decade of unprecedented expansion, set to nearly double in size from USD 28.5 billion in 2025 to USD 58.2 billion by 2035, registering a robust CAGR of 7.4%. This remarkable growth reflects the rising demand for advanced pharmaceutical packaging systems that enhance sterility, improve drug safety, and streamline regulatory compliance.
The market's trajectory is not just about scaling revenue but also about reshaping…

3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecas …
The 3D printing in healthcare industry stands at the threshold of a decade-long expansion trajectory that promises to reshape medical manufacturing and personalized healthcare technology. The market's journey from USD 4.2 billion in 2025 to USD 18.8 billion by 2035This remarkable growth underscores the technology's pivotal role in advancing personalized medicine, surgical precision, and medical device manufacturing, making it an investment priority for forward-looking manufacturers and healthcare technology leaders.Driven by…

Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growi …
The global surgical navigation glasses market is expected to reach USD 6,793 Million by 2035, up from estimated value of USD 423.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 32.0%.This exponential trajectory underscores the industry's pivotal role in transforming modern surgical practices, particularly in neurosurgery, orthopedics, and minimally invasive procedures.
Fueled by the rapid adoption of Augmented Reality…
More Releases for Antibodies
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The arthritis monoclonal antibodies…
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights:
• Global & Regional Market Analysis
• Global Multispecific Antibodies Market Opportunity: > USD 40 Billion
• Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion
• Number Of Approved Multispecific Antibodies: 14
• Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight
• Approved Antibodies Dosage & Pricing Insight
• Number Of Multispecific Antibodies: In Clinical Trials: > 900
• Comprehensive Insight On All Antibodies In Clinical Trials By…
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:
• Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms
• Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023)
• Global Bispecific Antibodies Market Size 2023: > USD 8 Billion
• Global Bispecific Antibodies Market Forecast Till 2029
• Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023)
• Approved Bispecific Antibodies Regional Sales (2018 till 2023)
• Clinical and Commercial Insight On Approved…
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
Tetravalent antibodies are designed to engage…